Edition:
India

TG Therapeutics Inc (TGTX.OQ)

TGTX.OQ on NASDAQ Stock Exchange Capital Market

12.20USD
16 Feb 2018
Change (% chg)

$-0.45 (-3.56%)
Prev Close
$12.65
Open
$12.65
Day's High
$12.90
Day's Low
$12.10
Volume
161,052
Avg. Vol
284,518
52-wk High
$15.35
52-wk Low
$4.53

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.04 -0.485
Jun '17 0.04 -0.448
Mar '17 0.04 -0.522
FY 2016 Dec '16 0.04 -0.480
Sep '16 0.04 -0.505
Jun '16 0.04 -0.326
Mar '16 0.04 -0.283
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 2 0.02 0.04 0.00 --
Quarter Ending Jun-18 2 0.02 0.04 0.00 --
Year Ending Dec-18 6 0.11 0.20 0.00 1.37
Earnings (per share)
Quarter Ending Mar-18 5 -0.43 -0.28 -0.48 --
Quarter Ending Jun-18 5 -0.42 -0.26 -0.48 --
Year Ending Dec-18 6 -1.70 -1.08 -1.96 -1.57
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 0.00 0.00 --
EPS (TTM) % -15.71 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for TG Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 58.02%
# of Holders: 153
Total Shares Held: 40,992,228
3 Mo. Net Change: 227,051
# New Positions: 18
# Closed Positions: 12
# Increased Positions: 82
# Reduced Positions: 35
# Net Buyers: 47
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.